Global Custom Market Research Reports Provider Company

phone

MediWound Ltd (MDWD) - Financial and Strategic SWOT Analysis Review

  • Published Date: 20 Jun 2018
  • Number of Pages: 46
  • Category: SWOT Analysis
  • Country: Israel
MediWound Ltd (MDWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MediWound Ltd (MediWound) is a biopharmaceutical company that offers burn and chronic wound management products based on patented proteolytic enzyme technology. The company offers its marketed product: nexobrid, which is used for the removal of eschar in adults with deep partial and full-thickness thermal burns. It also develops other wound care pipeline products, which are in development stages that include EscharEX and MWPC003. The company provides development, manufacturing and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. It caters to healthcare professionals and patients with burn wounds. MediWound is headquartered in Yavne, Israel.

MediWound Ltd Key Recent Developments

May 10,2018: MediWound Reports First Quarter 2018 Financial Results
Mar 19,2018: MediWound Announces Fourth Quarter And Fiscal Year 2017 Financial Results
Nov 16,2017: MediWound Reports Third Quarter 2017 Financial Results
Oct 25,2017: MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors
Aug 03,2017: MediWound Reports Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
MediWound Ltd - Key Facts 5
MediWound Ltd - Key Employees 6
MediWound Ltd - Key Employee Biographies 7
MediWound Ltd - Major Products and Services 8
MediWound Ltd - History 9
MediWound Ltd - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 Company Analysis 12
Company Overview 12
MediWound Ltd - Business Description 13
R&D Overview 13
MediWound Ltd - SWOT Analysis 14
SWOT Analysis - Overview 14
MediWound Ltd - Strengths 14
MediWound Ltd - Weaknesses 15
MediWound Ltd - Opportunities 16
MediWound Ltd - Threats 17
MediWound Ltd - Key Competitors 18
Section 3 Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 Companys Lifesciences Financial Deals and Alliances 26
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
MediWound Ltd, Recent Deals Summary 28
Section 5 Companys Recent Developments 29
May 10, 2018: MediWound Reports First Quarter 2018 Financial Results 29
Nov 16, 2017: MediWound Reports Third Quarter 2017 Financial Results 31
Oct 25, 2017: MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors 33
Aug 03, 2017: MediWound Reports Second Quarter 2017 Financial Results 34
May 18, 2017: MediWound Announces Changes to its Board of Directors 36
May 08, 2017: MediWound Reports First Quarter 2017 Financial Results 38
Feb 21, 2017: MediWound Reports 2016 Fourth Quarter and Full Year Financial Results 40
Section 6 Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List Of Tables

List of Tables
MediWound Ltd, Key Facts 5
MediWound Ltd, Key Employees 6
MediWound Ltd, Key Employee Biographies 7
MediWound Ltd, Major Products and Services 8
MediWound Ltd, History 9
MediWound Ltd, Subsidiaries 11
MediWound Ltd, Key Competitors 18
MediWound Ltd, Ratios based on current share price 19
MediWound Ltd, Annual Ratios 20
MediWound Ltd, Annual Ratios (Cont...1) 21
MediWound Ltd, Annual Ratios (Cont...2) 22
MediWound Ltd, Interim Ratios 24
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
MediWound Ltd, Recent Deals Summary 28
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

List Of Figures

List of Figures
MediWound Ltd, Performance Chart (2013 - 2017) 23
MediWound Ltd, Ratio Charts 25
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
MediWound Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas

View Report

MediWound Ltd (MediWound) is a biotechnology company that offers burn and chronic wound management products. The company offers nexobrid, which is used for the removal of eschar in adults with

View Report

MediWound Ltd (MDWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports